Large-scale testing (Phase 3)Ended earlyNCT00689390
What this trial is testing
Three-year Follow-up of Participants After Administration of Boceprevir or Narlaprevir for the Treatment of Chronic Hepatitis C (P05063)
Who this might be right for
Hepatitis C, ChronicHepacivirus
Merck Sharp & Dohme LLC 1,954